PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33830232-4 2021 ACA inhibited Caspase-1 activation and IL-1beta production by NLRP3 agonists such as nigericin, monosodium urate (MSU) crystals, and ATP. Nigericin 85-94 interleukin 1 alpha Mus musculus 39-47 33909257-5 2021 Bavachin boosts the secretion of IL-1beta and caspase-1 caused by ATP or nigericin but not those induced by poly(I:C), monosodium urate crystal, or intracellular lipopolysaccharide. Nigericin 73-82 interleukin 1 alpha Mus musculus 33-41 34861244-13 2022 In vitro, MaR1 could significantly suppressed the expression of NLR family pyrin domain containing 3 (NLRP3) inflammasome, GSDMD-N, and IL-1beta caused by LPS and nigericin stimulation in BMDMs. Nigericin 163-172 interleukin 1 alpha Mus musculus 136-144 35436667-7 2022 Among this series, compound 13a exhibited the most potent cellular NLRP3 inhibitory effect with an IC50 value of 49 nM, and significantly suppressed LPS/Nigericin-induced secretion of active caspase-1 and mature IL-1beta in a dose-dependent manner to block the activation of NLRP3 inflammasome. Nigericin 153-162 interleukin 1 alpha Mus musculus 212-220 31616405-11 2019 DHA pre-incubation suppressed inflammasome activation and release of IL-1beta and IL-1alpha by nigericin, cSiO2, and two other crystals - monosodium urate and alum. Nigericin 95-104 interleukin 1 alpha Mus musculus 82-91 33440601-5 2021 Ac2-26 administration reduced NLRP3-derived IL-1beta production by WT neutrophils after nigericin and ATP stimulation. Nigericin 88-97 interleukin 1 alpha Mus musculus 44-52 32733353-9 2020 Nigericin administration enhanced ASC oligomerization, caspase-1 and IL-1beta maturation without increasing the protein level of NLRP3, and ASC oligomerization and caspase-1 IL-1beta maturation reduced when combined with NEK7 knockdown or MCC950 delivery. Nigericin 0-9 interleukin 1 alpha Mus musculus 69-77